AVIR (Atea Pharmaceuticals) Institutional Ownership: 80.38% (As of Jul. 06, 2026)


AVIR Atea Pharmaceuticals Inc AVIR
24 GF Score
Price $4.87
! 3 Warning Signs
View Full Analysis

What is Atea Pharmaceuticals Institutional Ownership?

Atea Pharmaceuticals AVIR -2.21% 24 Institutional Ownership is 80.38% as of Jul. 06, 2026. GuruFocus rates AVIR with a GF Score™ of 24/100. The stock has 3 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Atea Pharmaceuticals's institutional ownership is 80.38%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Atea Pharmaceuticals's Insider Ownership is 3.92%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Atea Pharmaceuticals's Float Percentage Of Total Shares Outstanding is 77.51%.

Atea Pharmaceuticals Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Atea Pharmaceuticals's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Atea Pharmaceuticals Institutional Ownership Chart

Atea Pharmaceuticals Historical Data

The historical data trend for Atea Pharmaceuticals can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 35.32 37.82 39.65 39.42 40.19 40.95 39.85 39.22 39.67 39.90
AVIR
24GF Score
Atea Pharmaceuticals Inc AVIR
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Atea Pharmaceuticals Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 80.38% mean?
Atea Pharmaceuticals (AVIR) has a Institutional Ownership of 80.38% as of Jul. 06, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Atea Pharmaceuticals and its competitors.
Is Atea Pharmaceuticals' Institutional Ownership too high?
Atea Pharmaceuticals' current Institutional Ownership is 80.38%. Overall, Atea Pharmaceuticals has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Atea Pharmaceuticals' Institutional Ownership compare to VNDA and TENX?
Atea Pharmaceuticals' Institutional Ownership of 80.38% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Atea Pharmaceuticals and its competitors. Atea Pharmaceuticals's current Institutional Ownership is 80.38%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Atea Pharmaceuticals stock overvalued right now?
Atea Pharmaceuticals (AVIR) has a current Institutional Ownership of 80.38%. The current Institutional Ownership is 80.38%. Atea Pharmaceuticals' overall GF Score™ is 24/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Atea Pharmaceuticals (AVIR), the current Institutional Ownership is 80.38% as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Atea Pharmaceuticals Business Description

Address 225 Franklin Street, Suite 2100, Boston, MA, USA, 02110
Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.
24GF Score

Get the complete analysis for AVIR

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.87
Price